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A B S T R A C T
Combretum duarteanum Cambess, Combretaceae, is a plant widely distributed in Northeastern 
Brazil and, in folk medicine, stems and leaves are used for pain treatment. We investigated 
the antinociceptive effects of the hexanic extract of leaves from C. duarteanum and of friedelin, 
its main compound, in formalin-, glutamate- and capsaicin- induced orofacial nociception 
models. In order to isolate friedelin from the hexanic extract, flash chromatography technique 
was used. Male mice (n = 8/group) were pretreated with hexanic extract, friedelin, morphine 
or vehicle, before the injection of algogen agents into the right upper lip (perinasal area). 
The test of formalin-induced orofacial nociception showed that hexanic extract and friedelin 
significantly reduced nociception (p < 0.001) in both phases of testing. In the glutamate and 
capsaicin-induced orofacial nociception tests, pre-treatment with hexanic extract produced a 
significant reduction of orofacial nociception (p < 0.001) at all doses tested. The results suggest 
the hexanic extract and friedelin possess antinociceptive effects in models of orofacial 
nociception in rodents.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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Introduction 
Pain is defined as a subjective, unpleasant, physical and 
psychological experience observed as a result of the stimulation 
of identifiable nerve fibres with defined pathways towards the 
brain via the spinal cord (Agbaje et al., 2008; Palecek and Willis, 
2005). The orofacial region is an area densely innervated by the 
trigeminal nerve. The latter focuses some of the most common 
acute, chronic and referred pains, such as migraine, trigeminus 
neuralgia, post-herpetic neuralgia and teeth pain; however, the 
precise mechanisms of these pains are still poorly understood 
(Moalem and Tracey, 2006; Takemura et al., 2006). According to 
Hargreaves (2011), the management of orofacial pain continues 
to be a major challenge for medicine. 
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Currently, numerous therapeutic approaches are being 
used in order to control orofacial pain. A current approach is 
the development of new biological compounds from natural 
products (Siqueira et al., 2010; Venâncio et al., 2011; Guimarães 
et al., 2013).
Data from the literature show that species of the genus 
Combretum, Combretaceae, are rich in terpenoids that have 
a broad spectrum of biological activities including analgesic, 
anti-inflammatory, antibacterial, anticancer and antiprotozoal 
(Osborne and Pegel, 1984; Facundo et al., 1993; Pietrovski et 
al., 2006). Pietrovski et al. (2006) demonstrated that triterpenes 
isolated from C. leprosum had a significant antinociceptive 
effect in rodents.
Lima et al. (2012) described several compounds present in 
genus Combretum including triterpenes, such as friedelin, with 
important biological activities. Friedelin isolated from Aucuba 
jabonica showed anti-inflammatory activity in acute studies 
such as carrageenan-induced paw edema, histamine and 
compound 48/80-induced paw edema (Shimizu and Tommo, 
1994). Recently, Antonisamy et al. (2011) showed that friedelin 
(isolated from Azima tetracantha) possesses potent anti-
inflammatory, analgesic and antipyretic properties.
Combretum duarteanum Cambess. is a plant found in Northern 
and Northeastern Brazil, popularly known as “vaqueta” or 
“caatinga-branca”, used in folk medicine in the preparation 
of teas, drinks and food supplement for the treatment of 
painful conditions, including orofacial pain (Albuquerque 
et al., 2007; Gouveia et al., 2011). Lately, Gouveia et al. (2011) 
observed that the ethanolic extract obtained from leaves of 
the C. duarteanum exhibited an antioxidant, anti-inflammatory 
and antinociceptive effects. More recently, Lima et al. (2012) 
demonstrated that the hexane extract obtained from leaves 
of the C. duarteanum produced strong gastro-protective 
activity probably due to the presence of two triterpenes and 
involvement of nitric oxide (NO) and sulfhydryl (SH) pathways. 
Until now, no data exist concerning the possible orofacial 
antinociceptive effect of C. duarteanumor friedelin.
Thus, the purpose of the present study was to evaluate the 
antinociceptive effect of the hexanic extract of leaves from 
C. duarteanum and friedelin, its major compound, in different 
models of orofacial nociception on rodents.
Material and methods
General experimental procedures 
The melting point (m.p.) was measured using a Microquímica 
MQAPF-301 Model. IR spectra were acquired on a Biorad FTS-
3500 GX spectrophotometer. GC-MS analyses were performed 
on a Shimadzu QP5050A GC-MS system equipped with an 
AOC-20i autoinjector. The chromatograph used was equipped 
with a J & W Scientific DB-5MS (coated with 5%-phenyl-95%-
methylpolysiloxane) fused capillary column (30 m × 0.25 mm 
× 0.25 μm film thickness). MS were taken at 70 eV with a scan 
interval of 0.5 s and fragments of 40-500 Da. 1D and 2D NMR 
data were recorded at 293 K in CDCl3 on a Bruker Avance III 400 
NMR spectrometer, operating at 9.4 Tesla, observing 1H and 13C 
at 400.13 and 100.61 MHz, respectively. The spectrometer was 
equipped with either a 5-mm multinuclear direct detection 
probe (1D NMR experiments) or a 5-mm multinuclear inverse 
detection probe (2D NMR experiments), both with z-gradient. 
One-bond and long-range 1H-13C correlation from HSQC 
and HMBC NMR experiments were optimized for an average 
coupling constant 1J(C,H) and
 LRJ(C,H)of 140 and 8 Hz, respectively. 
All 1H and 13C NMR chemical shifts (G) are given in ppm related 
to the TMS signal at 0.00 ppm as an internal reference, and the 
coupling constants (J) in Hz. Silica gel 60 (Merck, 230-400 mesh) 
was used for column chromatography while precoated silica gel 
plates (Merck, 60 F254, 0.25 mm) were used for analytical TLC. 
Compounds were visualized by spraying with p-anisaldehyde 
reagent followed by heating on a hot plate.
Plant material
Leaves of Combretum duarteanum Cambess. (Combretaceae), 
were collected in the region around Serra Branca, Paraíba, 
Brazil, in March 2007. The plant was authenticated by Prof. 
Maria de Fátima Agra from the Federal University of Paraíba, 
and a voucher specimen was deposited at the Lauro Pires 
Xavier Herbarium (Voucher Nº 6767).
Extraction and isolation of friedelin
The dried leaves (1 kg) were powdered and extracted with 
ethanol, stirred and macerated at room temperature for 
approximately 48 h, and the procedure was repeated three 
times. The solvent was fully evaporated under reduced 
pressure, yielding 200 g of ethanol extract. The ethanol extract 
underwent liquid-liquid partition with hexane, obtaining 65.48 
g of hexane extract (HE). Such step was repeated to secure the 
required quantity for the study (Lima et al., 2013). The hexane 
extract (1 g) was submitted to column chromatography eluted 
with CHCl3:MeOH 95:05 (v/v), resulting in thirty fractions of 
50 ml each. The eluted fractions were evaluated and pooled 
according to TLC analysis, affording ten fractions (F-1 to 
F-10). F-3 was presented as a yellow light amorphous material 
submitted to recrystallization with methanol, obtaining in 
the end of the process a white amorphous solid, which was 
submitted to spectroscopic analysis, such as 1D and 2D NMR 
experiments, IR and Mass.
Friedelin (1): white amorphous solid, m.p. 259-260ºC 
(lit. 261-262ºC, Subhadhirasakul and Pechpongs, 2005); IR 
(KBr)Qmax 1720 cm-1; EIMS m/z (% intensity): 426 ([Mr], 6.47), 
411([M-CH3
], 2.39), 302 (6.13), 273 (4.24), 246 (9.66), 231 
(11.87), 218 (14.08), 205 (14.47), 191 (15.22), 179 (15.57), 163 
(21.76), 149(10.02), 137 (16.45), 125 (31.80), 123 (40.97),109 
(49.73), 95 (64.89), 81 (62.00), 69 (91.43), 55 (100.00); The 1H and 
13C NMR data are in agreement with those from literature 
(Subhadhirasakul and Pechpongs 2005; Almeida 2011).
Animals
Male Swiss mice (27-33 g), 2-3 months of age, were used 
throughout this study. The animals were randomly housed in 
cages at 21 ± 2ºC on a 12 h light/dark cycle (lights on from 6 a.m. 
to 6 p.m.) with free access to food (Purina®, Brazil) and water. 
Before the experiments, the animals were acclimatized to the 
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laboratory for at least 1 h prior and were used only once for 
each test. Experiments were carried out between 9 a.m. and 2 
p.m. in a quiet room. All experiments involving the behavioral 
analysis were carried out by the same visual observer and in 
a blind manner. Experimental protocols were approved by 
the Animal Care and Use Committee (CEPA/UFS: 17/10) at the 
Federal University of Sergipe, and handling procedures were in 
accordance with the International Association for the Study of 
Pain (IASP) guidelines for the use of animals in pain research 
(Zimmermann, 1983). All efforts were made to minimize the 
number of animals used and their discomfort, and all behavior 
tests were performed under blind conditions.
Formalin-induced orofacial nociception 
The orofacial formalin test was performed according to 
previous studies (Clavelou et al., 1995; Luccarini et al., 2006). 
Mice were pretreated (orally, p.o.) with HE at doses of 100, 200 
and 400 mg/kg, friedelin (50 mg/kg, p.o.), vehicle (Tween 800.2%) 
or morphine (5 mg/kg) 60 min before the administration of 
formalin 2%. The possible involvement of the opioid system 
was evaluated by the administration of naloxone (1.5 mg/
kg, i.p.), a non-selective opioid antagonist, 30 min before the 
administration of treatment with the highest dose of HE or 
friedelin. 
The induction of nociception was performed through 
subcutaneous injection of formalin (20 μl, 2%) into the upper 
lip (perinasal area) of mice according to what was described 
by Luccarini et al. (2006), with adaptations (Quintans-Júnior 
et al., 2010). The first phase (neurogenic phase) occurs within 
the first 0-5 min after the administration of the nociceptive 
substance and this phase is followed by a latency period of 
about 10 min. Then, a second phase (inflammatory phase) 
occurs within 15-40 min after the administration of the 
nociceptive substance. Animals were observed individually in 
mirrored chambers (30 × 30 × 30 cm) to allow an unobstructed 
view of the orofacial region; the nociceptive behavior assessed 
during the two phases was the time during which the animals 
kept rubbing the orofacial region.
Glutamate- and capsaicin-induced orofacial nociception
The orofacial pain was induced by glutamate or capsaicin in 
mice as described earlier (Quintans-Júnior et al., 2010). Mice 
(n = 8, per group) were injected with 40 μl of glutamate (25 mM) 
or capsaicin (20 μl, 2.5 μg) subcutaneously into the right upper 
lip (perinasal area), using a 27 gauge needle. Capsaicin was 
dissolved in ethanol, dimethyl sulfoxide and distilled water 
(1:1:8). In pilot studies, rodents manifested pain-related face-
rubbing behavior following the capsaicin injection with  high 
intensity at 10-20 min period. Therefore, pain quantification 
was performed at this period by measuring the time (s) that 
animals spent face-rubbing the injected area with fore- or 
hindpaws. HE (100, 200 or 400 mg/kg, p.o.), friedelin (50 mg/
kg, p.o.) or vehicle (Tween 800.2%) were given to animals as 
described for formalin test, 1 h before the local injection of 
glutamate or capsaicin. Morphine (5 mg/kg, i.p.), administered 
1 h before the algogen, was included as a positive control. An 
additional group received a similar volume of capsaicin vehicle 
(data not shown).
Evaluation of the motor activity (Rota-rod test)
To investigate the possible interference of C. duarteanum or 
friedelin in the motor activity of the animals, we used the rota-
rod apparatus according to method described Quintans-Junior 
et al. (2010). Initially, the mice able to remain on the rota-rod 
apparatus (AVS®, Brazil) for more than 180 s (9 rpm) were 
selected 24 h before the test. Then, the selected animals were 
divided into five groups (n = 8, per group) and were pretreated 
systemically (p.o.) with HE or friedelin at the same doses of 
formalin test. The control group received vehicle (Tween 
800.2%) and standard group received diazepam (DZP, 3 mg/kg, 
i.p.). After 60, 120 and 240 min, each animal was submitted to 
the rota-rod apparatus and the time that the animals remained 
on the rotating rod was registered. The maximum time of stay 
of the animal on the rota-rod was 180 s.
Statistics analysis
Data obtained were expressed as mean and standard error 
of the mean (mean ± SEM) and the differences among the 
groups were evaluated by one-way analysis of variance 
(ANOVA) followed by Tukey’s test. In all cases, differences 
were considered significant if p < 0.05. All statistic analyses 
were performed using Graph Pad Prism 5.0 (Graph Pad 
Prism Software Inc., San Diego, CA, USA). The percentage 
of inhibition by an antinociceptive agent was determined 
using the following formula (Reanmongkol et al., 1994): 
Inhibition % = 100 x (control - experiment)/control.
Drugs and reagents
The drugs and reagents used in this study were morphine 
sulphate (Dimorf-Cristalia, Brazil), glutamate (Sigma, USA), 
capsaicin (Sigma, USA), naloxone (Res. Biochemicals Inc., USA), 
diazepam (União Química, Brazil) and formaldehyde (Merck, 
USA). The vehicle was 0.2% Tween 80 (Sigma, USA) dissolved 
in saline solution (NaCl 0.9%).
Results and discussion
The present study evaluates, in an unprecedented manner, the 
antinociceptive effect of hexanic extract (HE) obtained from 
Combretum duarteanum Cambess, Combretaceae, and friedelin 
(1), a triterpene, by formalin-, glutamate- and capsaicin-
induced orofacial nociception models in mice. For the first 
time, we demonstrate that the systemic administration, by 
oral route, of the HE and friedelin (100% from GC) doses which 
did not produce any motor performance alteration produced 
consistent antinociceptive effects in different models of 
orofacial nociception.
The isolated compound obtained was a white amorphous 
solid with m.p. 259-260ºC. The MS spectrum showed a 
molecular ion peak at m/z 426 Mr. The IR spectrum showed an 
intense band at 1720 cm-1 consistent with a six membered ring 
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skeleton containing a carbonyl group. The 1H NMR revealed 
signals for seven singlet methyls at G 1.18 (H-28), 1.05 (H-27), 
1.01 (H-26), 1.00 (H-30), 0.95 (H-29), 0.87 (H-25) and 0.72 (H-24), 
a doublet methyl at G0.88 (d, J = 6.6 Hz, H-23), a methine proton 
at G 2.25 (q, J = 6.8 Hz, H-4), and methylene protons at G 2.39 
(ddd, J = 13.7, 5.2, 2.0 Hz, H-2) and G 2.29 (ddd, J = 13.7, 7.0, 1.0 
Hz, H-2), respectively. No vinylic proton signal was observed. 
The remaining proton signals were at G 1.2-2.00.  These 1H 
NMR data showed that the isolated compound seemed to 
be friedelin (Subhadhirasakul & Pechpongs, 2005). The 13C 
NMR spectrum showed a total of thirty carbons, among them 
a ketone carbon at G 213.2 was observed. The remaining 29 
carbons showed signals of having chemical shifts between 
6.8 and 59.5 ppm. The 1H and 13C NMR data of the isolated 
compound were identical to those in the literature identified 
for friedelin (Subhadhirasakul & Pechpongs, 2005; Almeida et 
al., 2011). Therefore, the isolated compound was identified 
as the pentacyclic triterpene known as friedelin (1). The 
confirmation of the structure of the isolated compound was 
supported by HMBC and HSQC experiments, and comparison to 
literature data (Subhadhirasakul & Pechpongs, 2005; Almeida 
et al., 2011).
in Table 1). As expected, naloxone reversed the analgesic 
effect of morphine. However, it did not alter the analgesic 
activity of the HE in a higher dose, and friedelin.
Beforehand, Antonisamy et al. (2011) had actually 
demonstrated that friedelin does not act through opioid 
pathways. Conversely, Gouveia et al. (2011) suggested that 
ethanolic extract (EE) from leaves of the C. duarteanum 
produced antinociceptive effect by the enhacement of the 
opioid pathway. Perhaps, EE contains compounds, different 
from friedelin, that contribute to the analgesic profile, such 
as what was shown by Lima et al. (2012). Those results 
suggest that the analgesic effect may act both by inhibiting 
the release of substance P and by inhibiting the arachidonic 
acid cascade reducing the production of inflammatory 
molecules, such as serotonin, histamine, bradykinin and/or 
prostaglandins (Luccarini et al., 2006). Another possibility for 
the inconsistence in results is probably related to the different 
types of models of nociception evaluated, and also because 
of the different areas studied, since the orofacial nociception 
involves the trigeminal system which presents complex and 
unique physiological characteristics compared to the spinal 
nociceptive system (Conti et al., 2003).
To evaluate whether an important pathway is involved 
with the analgesic profile of HE and friedelin, we investigated 
them in glutamate-induced orofacial nociception test. 
Glutamate, which is an excitatory neurotransmitter, present 
in both central and peripheral terminals of trigeminal 
and dorsal root ganglion neurons, has been used as a 
pharmacological tool in studies of orofacial nociception in 
animals for testing the effect of analgesic drugs, such as 
natural products or new drugs (Quintans-Júnior et al., 2010). 
Primary afferent fibers are sensitized by nerve or tissue injury 
or by response to noxious stimuli, it occurs by the release of 
amino acids from the central and spinal afferents trigeminal 
(Keast and Stephensen, 2000; Lam et al., 2005). Now, we 
showed that pretreatment with HE or friedelin promoted a 
significant decrease (p < 0.001) in the time the animals kept 
rubbing the orofacial region behavior as compared to the 
control group. Those results suggest a possible interaction 
with the glutamatergic system. Hence, the nociceptive 
response caused by glutamate seems to involve peripheral, 
spinal, and supra-spinal sites, and its action is mediated by 
NMDA (N-methyl-D-aspartate) and non-NMDA receptors (Lam 
et al., 2005; Fundytus, 2001; Beirith et al., 2002).
Capsaicin (8-methyl-N-vanillyl-6-trans-nonenamide) is the 
strong ingredient in hot chili peppers of the Capsicum genus, 
and it selectively activates the unmyelinated C-fibre class 
of nociceptors (Caterina et al., 1997). Capsaicin is used as a 
pharmacological tool for the study of nociception because 
when applied to skin, muscle and other tissues it produces 
inflammation, It activates and sensitizes the trigeminal 
and spinal small-diameter nociceptive afferents, as well 
as dorsal horn neurons (Hu et al., 2005; Lam et al., 2009). 
Table 2 shows that all doses tested of HE and friedelin 
produced a significant decrease (p < 0.001) in nociceptive 
behavior induced by capsaicin, in comparison to the control 
group (vehicle). This finding may be related to a possible 
inhibition of substance P release or due to a direct block of 
its receptor neurokinin-1 (NK -1). The tonic activation of NK-1 
The formalin test is a valuable tool widely used in studies 
of pain in animals and it is a reliable model for study of the 
behavior of the intensity coding of orofacial nociceptive 
stimulation and counter-irritation phenomena, as well as 
for testing the effect of analgesic drugs (Luccarini et al., 
2006). During the orofacial formalin test, two distinct phases 
due to different mechanisms of nociception are produced: 
the first phase is associated to the direct stimulation of 
C-nociceptors and it corresponds to the neurogenic pain 
acutely sensitive to drugs interacting with the opioid 
system, whereas the second phase reflects integration 
between nociceptors and spinal and brainstem signaling, 
and corresponds to inflammatory pain, being inhibited by 
cyclooxygenase (COX) inhibitors and supposed to depend 
on central neural changes induced by afferent generated 
activity during the initial phase in the local inflammatory 
response. Face rubbing due to formalin injection into the 
upper lip (perinasal region), has been mentioned as a 
specific nociceptive response (Dallel et al., 1995; Raboisson 
and Dallel, 2004). It was observed that all doses tested of 
HE and friedelin were able to significantly decrease (p < 
0.001) the time that the animal kept displaying rubbing 
the orofacial region, in both phases of formalin test, in 
comparison with the control group (vehicle) (As shown 
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receptors through the administration of the NK-1 receptor 
antagonist SR14033 blocked the second phase of the orofacial 
formalin test in rodents (Raboisson & Dallel, 2004). Waning 
et al. (2007) demonstrated that capsaicin-sensitive receptor 
potential vanilloid transient 1 (TRPV1), which plays an 
important role in pain transduction, is a Ca influx channels 
involved in cell migration. Additionally, Honda et al. (2008) 
suggests that TRPV1 receptor mechanisms in mouse facial 
skin responses influence the nociceptive cutaneous noxious 
thermal and mechanical stimulus, inducing neuroplastic 
changes in the caudal subnucleus (Vc) neurons and C1-C2.
All nociceptive tests conducted in the present study have a 
motor response as indicative of nociceptive behavior (rubbing 
the orofacial region- face regional). However, drugs that 
interfere with motor activity or induce sedation may give false-
positive nociceptive results in these tests. Thus, we performed 
the rota-rod test, which provides subsidies for a good index for 
neurological deficits including sedation, muscle relaxant and 
decreased motor activity (Pu et al., 1995; Novas et al., 1998; 
Quintans-Júnior, 2010). We did not register any significant 
alteration in motor performance for HE and friedelin (data not 
shown). 
Treatment
Time (s)
Dose 0-5 min 15-40 min
(mg/kg) Painful responsea % inhibition Painful responsea % inhibition
Vehicle - 81.5 ± 6.6 - 87.8 ± 9.4 -
HE 100 37.6 ± 5.3
c 53.8 65.3 ± 13.0b 25.6
HE 200 29.2 ± 1.8
c 64.2 54.0 ± 8.0c 38.5
HE 400 38.6 ± 4.6
c 52.6 48.6 ± 6.9c 44.6
)&/"-  26.0 ± 2.3
c 68.1 19.0 ± 9.5c 78.4
Friedelin (1) 50 33.5 ± 8.1
c 58.9 21.9 ± 7.7c,d 75.1
'SJFEFMJO/"-  29.8 ± 7.3
c 63.4 28.4 ± 5.4 c,d 67.7
Morphine 5 9.5 ± 1.8
c 88.3 19.1 ± 2.0c 78.2
.03/"-  70.6 ± 4.3 13.3 81.6 ± 5.8 7.1
 N = 8, per group. 
aValues represent mean ± S.E.M. 
bp < 0.05 (one-way ANOVA and Tukey’s test), significantly different from control. 
cp < 0.001 (one-way ANOVA and Tukey’s test), significantly different from control. 
dp < 0.05 (one-way ANOVA and Tukey’s test), significantly different from HE 400 mg/kg group.
Table 1
Effect of HE, friedelin or morphine (MOR) in formalin-induced orofacial nociception, in presence and absence of naloxone 
(NAL), in rodents.
Treatment
Dose Glutamate test Capsaicin test
 (mg/kg) Painful responsea % inhibition % inhibition % inhibition
Vehicle - 105.3 ± 13.2 - 98.5 ± 9.1 -
HE 100 53.6 ± 8.1
b 49.1 40.1 ± 7.2b 59.3
HE 200 48.3 ± 7.5
b 54.1 34.9 ± 6.8b 64.6
HE 400 43.5 ± 11.0
b 58.7 26.5 ± 8.1b 73.1
Friedelin (1) 50 40.1 ± 9.2
b 61.9 29.6 ± 8.3b,c 69.9
Morphine 5 19.5 ± 7.7
b 81.5 14.3 ± 2.3b 85.5
n = 8, per group. 
aValues represent mean ± S.E.M. 
bp < 0.001 (one-way ANOVA and Turkey`s test), significantly different from control group. 
cp < 0.05 (one-way ANOVA and Turkey`s test), significantly different from HE 100 mg/kg group.
Table 2
Effect of HE, friedelin or morphine in glutamate- or capsaicin-induced orofacial nociception in rodents.
 Jullyana de Souza Siqueira Quintans et al. / Rev Bras Farmacogn 24(2014): 60-66 65
Conclusions
It can be concluded that the antinociceptive profile of EH 
and friedelin probably occurs via central and peripheral 
pathways, modulating the inflammatory and neuropathic 
pain, but without opioid system involvement. The friedelin 
seems, at least in part, to contribute to the explanation of 
the antinociceptive properties of C. duarteanum extract. 
Furthermore, the antinociceptive action demonstrated in the 
present study supports, at least partly, the ethnomedical use 
of this medicinal plant.
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